ANDA 89220, held by IDT Australia. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 89220 (Procainamide Hydrochloride), held by IDT Australia, was first approved by FDA on Jul 1, 1986, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 1, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Procainamide Hydrochloride375MG · capsule;oral | Procainamide Hydrochloride | Discontinued |
| Feb 14, 1991 | Supplement 5Labeling | Approved | None posted |
| Oct 20, 1988 | Supplement 4Labeling | Approved | None posted |
| Jul 1, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters